Dendritic Cells—A Conductor of T Cell Differentiation—

Induction of different types of adaptive immune responses depending on the nature of antigens and the environmental context is crucial to cope with a variety of pathogens and concurrently to avoid pathological reaction to self antigens. Recent studies have been elucidating that the diversity of immu...

Full description

Bibliographic Details
Main Author: Norimitsu Kadowaki
Format: Article
Language:English
Published: Elsevier 2007-01-01
Series:Allergology International
Subjects:
Th1
Th2
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893015308650
id doaj-c5ff1382a80640eb8a0142eae200d942
record_format Article
spelling doaj-c5ff1382a80640eb8a0142eae200d9422020-11-24T22:36:09ZengElsevierAllergology International1323-89302007-01-0156319319910.2332/allergolint.R-07-146Dendritic Cells—A Conductor of T Cell Differentiation—Norimitsu Kadowaki0Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.Induction of different types of adaptive immune responses depending on the nature of antigens and the environmental context is crucial to cope with a variety of pathogens and concurrently to avoid pathological reaction to self antigens. Recent studies have been elucidating that the diversity of immune responses is critically controlled by dendritic cells (DCs). Two DC subsets have been identified in humans: myeloid DCs and plasmacytoid DCs. The DC subsets induce different types of adaptive immune responses depending on environmental factors. Interleukin (IL)-12 from myeloid DCs is a dominant factor for the induction of a Th1 response, whereas OX40 ligand on myeloid DCs is important for the induction of a Th2 response. Furthermore, inducible costimulator (ICOS) ligand on plasmacytoid DCs is critical for the induction of IL-10-producing regulatory T cells. Elucidating cellular and molecular mechanisms by which functions of the two DC subsets are modulated will lead to understanding the pathogenesis of various immune-related diseases and to developing novel immunological therapies.http://www.sciencedirect.com/science/article/pii/S1323893015308650dendritic cellsregulatory T cellsTh1Th2Th17
collection DOAJ
language English
format Article
sources DOAJ
author Norimitsu Kadowaki
spellingShingle Norimitsu Kadowaki
Dendritic Cells—A Conductor of T Cell Differentiation—
Allergology International
dendritic cells
regulatory T cells
Th1
Th2
Th17
author_facet Norimitsu Kadowaki
author_sort Norimitsu Kadowaki
title Dendritic Cells—A Conductor of T Cell Differentiation—
title_short Dendritic Cells—A Conductor of T Cell Differentiation—
title_full Dendritic Cells—A Conductor of T Cell Differentiation—
title_fullStr Dendritic Cells—A Conductor of T Cell Differentiation—
title_full_unstemmed Dendritic Cells—A Conductor of T Cell Differentiation—
title_sort dendritic cells—a conductor of t cell differentiation—
publisher Elsevier
series Allergology International
issn 1323-8930
publishDate 2007-01-01
description Induction of different types of adaptive immune responses depending on the nature of antigens and the environmental context is crucial to cope with a variety of pathogens and concurrently to avoid pathological reaction to self antigens. Recent studies have been elucidating that the diversity of immune responses is critically controlled by dendritic cells (DCs). Two DC subsets have been identified in humans: myeloid DCs and plasmacytoid DCs. The DC subsets induce different types of adaptive immune responses depending on environmental factors. Interleukin (IL)-12 from myeloid DCs is a dominant factor for the induction of a Th1 response, whereas OX40 ligand on myeloid DCs is important for the induction of a Th2 response. Furthermore, inducible costimulator (ICOS) ligand on plasmacytoid DCs is critical for the induction of IL-10-producing regulatory T cells. Elucidating cellular and molecular mechanisms by which functions of the two DC subsets are modulated will lead to understanding the pathogenesis of various immune-related diseases and to developing novel immunological therapies.
topic dendritic cells
regulatory T cells
Th1
Th2
Th17
url http://www.sciencedirect.com/science/article/pii/S1323893015308650
work_keys_str_mv AT norimitsukadowaki dendriticcellsaconductoroftcelldifferentiation
_version_ 1725720971615141888